Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ASTRAZENECA PLC Stock Hits Price Target Forecast with 16.67% Profit – QuantWave Analysis

May 21, 2024
ASTRAZENECA PLC (NYSE: AZN) stock successfully reached its price target forecast as predicted by QuantWave's automated forecasting platform. The forecast signal was initiated on January 9, 2024, with the stock trading at 66.5 $. The direction of the forecast was long, indicating an opportunity for investors to benefit from a potential increase in the stock price.

On May 21, 2024, ASTRAZENECA PLC stock reached the target price of 77.59 $, realizing a profit of 16.67% for investors who followed the forecast. This achievement showcases the accuracy and effectiveness of QuantWave's analytical capabilities in predicting market movements.

Several factors could have contributed to the stock's movement towards the forecasted target. Positive developments in ASTRAZENECA PLC's pipeline of pharmaceutical products, promising clinical trial results, or overall market trends in the healthcare sector may have influenced the stock price during the forecast period.

QuantWave's forecasting platform offers users access to predictions for a wide range of stocks, presenting opportunities for potential profits through informed trading decisions. For investors looking to deepen their understanding of QuantWave's investment strategy, QuantSchool provides essential educational resources on the professional investment framework. QuantSchool details the key principles for generating consistent income using the QuantWave forecasting system, empowering investors to make sound financial decisions based on data-driven insights.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNJune 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know  ~1 min.

AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....

AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....

AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....

AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....

AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....

AZNMarch 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit  ~1 min.

On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....

AZNMarch 4, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy  ~2 min.

ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025....

AZNFebruary 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential  ~2 min.

AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....

AZNFebruary 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....

AZNFebruary 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....

AZNDecember 7, 2024Why AstraZeneca PLC AZN is Revolutionizing the Pharmaceutical Industry  ~2 min.

AstraZeneca PLC AZN, a leading multinational pharmaceutical company, is making groundbreaking strides in the industry....

AZNDecember 9, 2024Is AstraZeneca PLC AZN the Most Profitable Pharmaceutical Stock Right Now?  ~2 min.

AstraZeneca PLC (AZN) is emerging as one of the most profitable pharmaceutical stocks in the market....

AZNJanuary 1, 2025AstraZeneca PLC Expands Global Footprint with New Acquisition  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, has announced its latest acquisition, further expanding its global footprint in the healthcare industry....

AZNFebruary 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....

AZNAugust 15, 2024Achievement of Price Target Forecast for AstraZeneca PLC Generates Profit of 30.9%  ~1 min.

QuantWave, the automated forecasting platform, successfully predicted a price target for AstraZeneca PLC on October 3, 2023. The forecast indicated a long position with the stock priced at $63.95....